To support our newly established SFB TRR267, we are offering a
Junior research group leader position
“Non-coding RNA in the cardiovascular system”
starting at the earliest possible date.
About SFB TRR267
Diseases of the cardiovascular system are the main cause of death worldwide and there is high need for a better understanding of molecular disease mechanisms and improved therapy. Non-coding RNA molecules have come into focus of cardiovascular research, as they control key processes in the cardiovascular system and as successful manipulation in disease models in vivo underscores their therapeutic potential.
To foster research on non-coding RNA in the cardiovascular system, the German Research Foundation DFG has approved funding for a new transregio collaborative research center including five institutions under the leadership of the Technical University of Munich (TUM) and the Goethe University Frankfurt. Over the next four years, the consortium will receive funding of ~10 million €, with the option of continuation.
The Junior Research Group “Non-coding RNA in the cardiovascular system”
The new JRG will investigate the role of non-coding RNAs in the development, homeostasis or diseases of the cardiovascular system. It will be provided with an outstanding infrastructure and excellent research opportunities. The JRG will be sited in Munich at the Institute of Pharmacology and Toxicology at TUM, headed by the TRR267 speaker Prof. Dr. Dr. Stefan Engelhardt, and work in close collaboration with members at the Frankfurt, Hannover and Bad Nauheim sites. The TUM as one of the top-ranked universities in Europe offers promising young scientists attractive career perspectives with its new career model: TUM Faculty Tenure Track.
- Working in a nationally/internationally leading research environment on cardiovascular non-coding RNA.
- A state-of-the-art research facility, with mouse phenotyping, human iPS cell programming, flow cytometry, single-cell RNA Seq, 2-photon laser microscopy – to name a few.
- Participation in productive, multidisciplinary interactions with our collaborators.
- As member of the TUM, you will benefit from programs for early career support and programs to enhance compatibilityof family life and career.
The position is available instantly and initially limited to two years. Salary is according to level TVL-E14.
- Scientist with outstanding expertise in the field of RNA biology or a related discipline (e.g. structural biology, developmental biology, -omics or chemistry).
- Successful recipient of grants and early career programs (e.g. Emmy-Noether, Marie-Curie, Heisenberg).
- Proven track record of publications in highly visible international journals.
- Previous work in cardiovascular research is favorable, but not obligatory.
- You have a high degree of responsibility, are independent and enjoy working in a team.
TRR267 and its member institution TUM aim to substantially increase diversity of its staff. We therefore encourage applications from women as well as from all others who would bring additional diversity dimensions to the university’s research and teaching strategies. Preference will be given to disabled candidates with essentially the same qualifications. International candidates are highly encouraged to apply. Please send your application (cover letter, C.V., recommendations/references, certificates) via email to: email@example.com. Applications will be considered as they are received and until the position is filled.
Technische Universität München
Institut für Pharmakologie und Toxikologie
Prof. Dr. Dr. Stefan Engelhardt
Biedersteiner Straße 29
Tel. +49 89 4140 3260
Data Protection Information
Find out more about us at www.tum.de.